Backs FY24 revenue view down 0.5% to up 1.5%, consensus $9.37B. Sees FY24 organic net sales flat to up 2%. Sees FY24 adjusted EBIT up 3%-5%. The company said, “Given the sequential volume and margin improvement for its key brands and categories, the company is reaffirming its full-year fiscal 2024 guidance provided on August 31, 2023. Full year top-line growth rate is currently tracking to the lower end of the net sales guidance range, with possible upside should the pace of consumer recovery accelerate in the second half of the year. The company continues to expect sequential earnings and margin progress in the balance of the fiscal year reflecting a moderating inflationary environment and on-going productivity improvements.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CPB:
- Options Volatility and Implied Earnings Moves Today, March 06, 2024
- CPB Earnings this Week: How Will it Perform?
- Food stocks looking super cheap, could rally, Barron’s says
- TD Cowen food/agribusiness analyst holds an analyst/industry conference call
- GoodRx upgraded, Fisker downgraded: Wall Street’s top analyst calls